CAITLIN M SURIANO

Allopathic & Osteopathic Physicians|Allergy & Immunology CHANDLER, AZ NPI 1124594205

General Payments — all program years on this page

$4,085.82

  • Category: General Payments
  • Program years: PY2021–2023
  • Record count: 196
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $597.30 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $588.3119
Consulting Fee $8.991

By paying entity

Latest program year (PY2023) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $1,686.5487
2022 $1,801.9889
2023 $597.3020

Records — PY2023 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1003698305 GlaxoSmithKline, LLC. $26.47 09/14/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1003701117 GlaxoSmithKline, LLC. $16.11 12/20/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1011820659 Grifols USA, LLC $26.14 08/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1011820665 Grifols USA, LLC $23.07 05/19/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1011820667 Grifols USA, LLC $19.20 04/27/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1011862837 Grifols USA, LLC $21.46 02/22/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1011862843 Grifols USA, LLC $22.02 01/25/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1013074887 kaleo, Inc. $27.24 07/19/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1013074895 kaleo, Inc. $21.88 09/07/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1022978209 Bio Products Laboratory USA, Inc. $16.95 05/19/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1042937089 CSL Behring $17.14 04/20/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1042937107 CSL Behring $26.49 05/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1050455109 GENZYME CORPORATION $115.74 03/09/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1051632167 AstraZeneca Pharmaceuticals LP $15.50 05/30/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1051633121 AstraZeneca Pharmaceuticals LP $22.10 01/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1051634915 AstraZeneca Pharmaceuticals LP $100.42 02/21/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1056027857 Takeda Pharmaceuticals U.S.A., Inc. $25.04 02/08/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1056027859 Takeda Pharmaceuticals U.S.A., Inc. $27.14 02/14/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1058970045 ADMA BioManufacturing LLC $8.99 01/03/2023 Consulting Fee Undisputed 01/23/2026 View at CMS
971741653 Phadia US Inc. $18.20 08/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.